Member access

4-Traders Homepage  >  Shares  >  Nyse  >  UnitedHealth Group Inc.    UNH   US91324P1021

Delayed Quote. Delayed Nyse - 05/22 04:01:37 pm
119.59 USD   -0.72%
05/22 DOW MOVERS : Ba, axp
05/21 CVS to expand pharmacy business with $10.1 billion Omnicare buy
05/21DJCVS to Buy Omnicare For $12.7 Billion--5th Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales110 618122 489130 474143 724155 019166 123
Operating income (EBITDA)10 56310 99811 75212 49613 65714 932
Operating profit (EBIT)9 2549 62310 27411 11712 21113 488
Pre-Tax Profit (EBT)8 6228 915----
Net income5 5265 6255 6196 0266 6307 188
EPS ( $)5,285,505,706,257,028,07
Dividend per Share ( $)0,801,051,411,481,521,73
Yield0,67%0,88%1,17%1,24%1,27%1,44%
Announcement Date01/17/2013
11:00am
01/16/2014
11:00am
01/21/2015
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt8 3487 6478 1707 2575 6852 831
Finance------
Operating income (EBITDA)10 56310 99811 75212 49613 65714 932
Leverage
(Debt/EBITDA)
0,79x0,70x0,70x0,58x0,42x0,19x
Capital Expenditure1 0701 1611 4471 4191 4361 835
Book Value Per Share (BVPS)30,6 $32,5 $33,7 $37,2 $41,9 $45,2 $
Cash Flow per Share6,84 $6,83 $8,16 $8,38 $9,22 $9,67 $
Announcement Date01/17/2013
11:00am
01/16/2014
11:00am
01/21/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 113 838 M$ -
Entreprise Value (EV) 121 095 M$ 119 523 M$
Valuation 2015e 2016e
PER (Price / EPS) 19,1x 17,0x
Capitalization / Revenue 0,79x 0,73x
EV / Revenue 0,84x 0,77x
EV / EBITDA 9,69x 8,75x
Yield (DPS / Price) 1,24% 1,27%
Price to book (Price / BVPS) 3,22x 2,85x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 7,73% 7,88%
operating Leverage (Delta EBIT / Delta Sales) 0,81x 1,25x
Net Margin (Net Profit / Revenue) 4,19% 4,28%
ROA (Net Profit / Asset) 6,80% 8,00%
ROE (Net Profit / Equities) 17,3% 17,6%
Rate of Dividend 23,7% 21,7%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   0,99% 0,93%
Cash Flow / Sales (Taux d'autofinancement) 5,55% 5,66%
Capital Intensity (Assets / Sales) 0,62x 0,53x
Financial Leverage (Net Debt / EBITDA) 0,58x 0,42x
Price Earning Ratio
EPS & Dividend